Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.

MIT PhD students who interned with the MIT-IBM Watson AI Lab Summer Program are pushing AI tools to be more flexible, efficient, and grounded in truth.

Cultured from induced pluripotent stem cells, “miBrains” integrate all major brain cell types and model brain structures, cellular interactions, activity, and pathological features.

Using these antigens, researchers plan to develop vaccine candidates that they hope would stimulate a strong immune response against the world’s deadliest pathogen.

MIT researchers created microscopic wireless electronic devices that travel through blood and implant in target brain regions, where they provide electrical stimulation.

MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth following a heart attack.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.

A presidential initiative, the MIT Human Insight Collaborative is supporting new interdisciplinary initiatives and projects across the Institute.

The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.

New research shows attention lapses due to sleep deprivation coincide with a flushing of fluid from the brain — a process that normally occurs during sleep.

Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.

Exercise is Medicine class integrates physical activity and academics.

A beloved member of the Department of Mechanical Engineering for nearly 60 years, Yannas helped save the lives of thousands of burn victims through his research and innovation.

An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.

An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.

Professors Facundo Batista and Dina Katabi, along with three additional MIT alumni, are honored for their outstanding professional achievement and commitment to service.

Twelve START.nano companies competed for the grand prize of nanoBucks to be used at MIT.nano’s facilities.

The newest MIT engineering faculty are conducting research across a diverse range of subject areas.

Enabled by a new high-resolution mapping technique, the findings overturn a long-held belief that the genome loses its 3D structure when cells divide.

Their system uses electrochemically generated bubbles to detach cells from surfaces, which could accelerate the growth of carbon-absorbing algae and lifesaving cell therapies.

Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.

Speakers at MIT’s Aging Brain Initiative symposium described how immune system factors during aging contribute to Alzheimer’s, Parkinson’s and other conditions. The field is leveraging that knowledge to develop new therapies.

A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.

A leading researcher in protein folding biochemistry and next-generation protein engineering techniques will advance chemistry research and education.

MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.

The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.

The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.

A new study finds over half the drugs approved this century cite government-funded research in their patents.

By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.

Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.

Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.

The method enhances 3D bioprinting capabilities, accelerating process optimization‎ for real-world applications in tissue engineering.

Cache DNA has developed technologies that can preserve biomolecules at room temperature to make storing and transporting samples less expensive and more reliable.

Advance from SMART will help to better identify disease markers and develop targeted therapies and personalized treatment for diseases such as cancer and antibiotic-resistant infection.

A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.

Tom Zeller’s new book, “The Headache,” sheds light on one of the world’s most confounding and agonizing ailments.

Outfitted with antibodies that guide them to the tumor site, the new nanoparticles could reduce the side effects of treatment.

Professor Caroline Uhler discusses her work at the Schmidt Center, thorny problems in math, and the ongoing quest to understand some of the most complex interactions in biology.

A commitment from longtime supporters Patricia and James Poitras ’63 initiates multidisciplinary efforts to understand and treat complex psychiatric disorders.

VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.

Researchers developed a tool to recreate cells’ family trees. Comparing cells’ lineages and locations within a tumor provided insights into factors shaping tumor growth.

CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.

Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.

The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.

Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.

Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

Scaling up nanoparticle production could help scientists test new cancer treatments.